Patents by Inventor Meital Paz

Meital Paz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230094142
    Abstract: A method of classifying the severity of a coronaviral infection of a subject is disclosed. The method comprises measuring the TRAIL and/or IP10 protein level in a body liquid sample of the subject, wherein the level is indicative of the severity of the coronaviral infection. Managing treatments for coronaviral infections are also disclosed as well as measuring contagiousness of infections.
    Type: Application
    Filed: January 29, 2021
    Publication date: March 30, 2023
    Applicant: MeMed Diagnostics Ltd.
    Inventors: Niv Steven MASTBOIM, Oded SHAHAM, Roy NAVON, Tahel ILAN BER, Shaul LEV, Eran BARASH, Tanya Michelle GOTTLIEB, Meital PAZ, Olga BOICO, Kfir OVED, Eran EDEN
  • Publication number: 20220326256
    Abstract: A method of determining a management course for treating a subject showing symptoms of a disease is disclosed. The method comprises measuring the TRAIL protein level in a blood sample of the subject, wherein when the TRAIL level is below a predetermined amount, the subject is treated as a high-risk patient.
    Type: Application
    Filed: June 16, 2022
    Publication date: October 13, 2022
    Applicant: MeMed Diagnostics Ltd.
    Inventors: Eran EDEN, Kfir OVED, Assaf COHEN-DOTAN, Roy NAVON, Olga BOICO, Meital PAZ
  • Publication number: 20220326238
    Abstract: A method of measuring risk assessment in a patient with appendicitis is disclosed. The method comprises: (a) measuring the TRAIL protein level in a blood sample of the patient; and (b) providing a risk assessment based on the TRAIL protein level.
    Type: Application
    Filed: June 5, 2022
    Publication date: October 13, 2022
    Applicant: MeMed Diagnostics Ltd.
    Inventors: Kfir OVED, Eran EDEN, Assaf COHEN-DOTAN, Roy NAVON, Niv Steven MASTBOIM, Olga BOICO, Meital PAZ
  • Publication number: 20220236269
    Abstract: Methods of determining infection type are disclosed. In one embodiment, the method comprises measuring the amount of TRAIL and/or IP10 no more than two days from symptom onset.
    Type: Application
    Filed: April 11, 2022
    Publication date: July 28, 2022
    Applicant: MeMed Diagnostics Ltd.
    Inventors: Eran EDEN, Kfir OVED, Assaf COHEN-DOTAN, Roy NAVON, Olga BOICO, Meital PAZ
  • Patent number: 11385241
    Abstract: A method of determining a management course for treating a subject showing symptoms of a disease is disclosed. The method comprises measuring the TRAIL protein level in a blood sample of the subject, wherein when the TRAIL level is below a predetermined amount, the subject is treated as a high-risk patient.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: July 12, 2022
    Assignee: MeMed Diagnostics Ltd.
    Inventors: Eran Eden, Kfir Oved, Assaf Cohen-Dotan, Roy Navon, Olga Boico, Meital Paz
  • Patent number: 11353456
    Abstract: A method of measuring risk assessment in a patient with appendicitis is disclosed. The method comprises: (a) measuring the TRAIL protein level in a blood sample of the patient; (b) providing a risk assessment based on the TRAIL protein level.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: June 7, 2022
    Assignee: MeMed Diagnostics Ltd.
    Inventors: Kfir Oved, Eran Eden, Assaf Cohen-Dotan, Roy Navon, Niv Steven Mastboim, Olga Boico, Meital Paz
  • Patent number: 11340223
    Abstract: Methods of determining infection type are disclosed. In one embodiment, the method comprises measuring the amount of TRAIL and/or IP10 no more than two days from symptom onset.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: May 24, 2022
    Assignee: MeMed Diagnostics Ltd.
    Inventors: Eran Eden, Kfir Oved, Assaf Cohen-Dotan, Roy Navon, Olga Boico, Meital Paz
  • Publication number: 20220011320
    Abstract: Methods of diagnosing infections are disclosed. In one embodiment, the method comprises measuring the amount of each of the polypeptides TRAIL, CRP, IP10 and at least one additional polypeptide selected from the group consisting of IL-6 and PCT.
    Type: Application
    Filed: July 12, 2021
    Publication date: January 13, 2022
    Applicant: MeMed Diagnostics Ltd.
    Inventors: Eran EDEN, Kfir OVED, Assaf COHEN-DOTAN, Roy NAVON, Olga BOICO, Gali KRONENFELD, Meital PAZ, Ellen BAMBERGER
  • Patent number: 11131671
    Abstract: Methods of diagnosing infections are disclosed. In one embodiment, the method comprises measuring the amount of each of the polypeptides TRAIL, CRP, IP10 and at least one additional polypeptide selected from the group consisting of IL-6 and PCT.
    Type: Grant
    Filed: January 3, 2019
    Date of Patent: September 28, 2021
    Assignee: MeMed Diagnostics Ltd.
    Inventors: Eran Eden, Kfir Oved, Assaf Cohen-Dotan, Roy Navon, Olga Boico, Gali Kronenfeld, Meital Paz, Ellen Bamberger
  • Publication number: 20190271709
    Abstract: A method of determining a management course for treating a subject showing symptoms of a disease is disclosed. The method comprises measuring the TRAIL protein level in a blood sample of the subject, wherein when the TRAIL level is below a predetermined amount, the subject is treated as a high-risk patient.
    Type: Application
    Filed: September 27, 2017
    Publication date: September 5, 2019
    Applicant: MeMed Diagnostics Ltd.
    Inventors: Eran EDEN, Kfir OVED, Assaf COHEN-DOTAN, Roy NAVON, Olga BOICO, Meital PAZ
  • Publication number: 20190242895
    Abstract: Methods of determining infection type are disclosed. In one embodiment, the method comprises measuring the amount of TRAIL and/or IP10 no more than two days from symptom onset.
    Type: Application
    Filed: July 10, 2017
    Publication date: August 8, 2019
    Applicant: MeMed Diagnostics Ltd.
    Inventors: Eran EDEN, Kfir OVED, Assaf COHEN-DOTAN, Roy NAVON, Olga BOICO, Meital PAZ
  • Publication number: 20190242894
    Abstract: A method of measuring risk assessment in a patient is disclosed. The method comprises: (a) measuring the TRAIL protein level in a blood sample of the patient; (b) measuring the level of at least one disease-associated parameter in the patient; and (c) providing a risk assessment based on the combination of said TRAIL protein level and said disease-associated parameter level.
    Type: Application
    Filed: September 27, 2017
    Publication date: August 8, 2019
    Inventors: Kfir OVED, Eran EDEN, Assaf COHEN-DOTAN, Roy NAVON, Niv Steven MASTBOIM, Olga BOICO, Meital PAZ
  • Publication number: 20190120837
    Abstract: Methods of diagnosing infections are disclosed. In one embodiment, the method comprises measuring the amount of each of the polypeptides TRAIL, CRP, IP10 and at least one additional polypeptide selected from the group consisting of IL-6 and PCT.
    Type: Application
    Filed: January 3, 2019
    Publication date: April 25, 2019
    Applicant: MeMed Diagnostics Ltd.
    Inventors: Eran EDEN, Kfir Oved, Assaf Cohen-Dotan, Roy Navon, Olga Boico, Gali Kronenfeld, Meital Paz, Ellen Bamberger